Harrington Prize for Innovation in Medicine recognizes pioneering work in prostate cancer diagnosis and treatment CLEVELAND, March 24, 2026 /PRNewswire/ -- The thirteenth annual Harrington Prize for ...
Prostate cancer screening plans could be scaled back even further, despite growing calls for more testing to be rolled out.
A landmark trial aiming to shape the future of prostate cancer screening in the UK has begun testing a group of men ...
Over the past decade, advances in cancer genetics and oncogenomic have profoundly reshaped our understanding of pediatric tumors. Unlike adult cancers, ...
UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for targeting tumors that have long resisted treatment.
A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants. The ...
Medindia on MSN
Novel ctDNA blood test to track and treat prostate cancer
India, March 23 -- Advances in cancer research are improving how doctors diagnose and monitor diseases. One emerging tool is ...
UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for ...
MERGE network demonstrate responsible model for communicating genetic disease risk information to patients and care providers ...
UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...
While sales of Talzenna, which Pfizer acquired in a $14 billion deal, have been “negligible” so far, the new results should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results